newsfilter
← Latest News
Business Wire·

Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery

Goal is to help pharmaceutical innovators evaluate opportunities earlier and accelerate future central nervous system pipelines AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection